1 results match your criteria: "Laboratory of Medicinal Chemistry (Institute of Organic Chemistry[Affiliation]"
Acta Pharm Sin B
May 2023
Laboratory of Medicinal Chemistry (Institute of Organic Chemistry, CSIC); Madrid 28006, Spain.
We describe the development of quinolylnitrones (QNs) as multifunctional ligands inhibiting cholinesterases (ChEs: acetylcholinesterase and butyrylcholinesterase-hBChE) and monoamine oxidases (hMAO-A/B) for the therapy of neurodegenerative diseases. We identified QN , a simple, low molecular weight nitrone, that is readily synthesized from commercially available 8-hydroxyquinoline-2-carbaldehyde. Quinolylnitrone has no typical pharmacophoric element to suggest ChE or MAO inhibition, yet unexpectedly showed potent inhibition of hBChE (IC = 1.
View Article and Find Full Text PDF